FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1476-1480 May 26, 1994 Number 21 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The administration of surfactant decreased mortality, morbidity, and costs of care for very-low-birth-weight infants in clinical trials. The extent to which these benefits can be achieved in the usual clinical settings is not known.

Methods We analyzed clinical and financial data obtained from 1985 to 1990 at 14 perinatal centers in the United States on 5629 neonates weighing 500 to 1500 g. The infants were divided into groups according to whether they were born before or after surfactant was introduced into clinical practice. Regression models controlling for race, sex, and birth weight were used to assess mortality, morbidity, and use of resources. Mortality rates specific for these variables were projected to the nation as a whole with reference to the 1985 U.S. birth cohort.

Results The odds of death in the hospital for very-low-birth-weight infants were reduced by 30 percent after surfactant was introduced. Among infants with bronchopulmonary dysplasia, mortality declined 40 percent. Projections of mortality nationwide declined 5 percent. Eighty percent of the decline in the U.S. infant mortality rate between 1989 and 1990 could be attributed solely to the use of surfactant. Among the survivors, the overall odds of morbidity did not change, whether or not we adjusted for changes in race, sex, and birth weight. The odds of respiratory distress syndrome and pulmonary interstitial emphysema among the survivors declined by 20 percent and 40 percent, respectively, with surfactant. Inflation-adjusted charges per survivor declined by 10 percent, or $5,800, whereas the cost of care for each infant who died declined by 31 percent, or $4,400.

Conclusions The introduction of surfactant has led to decreased mortality and morbidity in very-low-birth-weight infants and to decreased use of resources both for infants who survive and for those who die.

Source Information

From the National Perinatal Information Center, Providence, R.I. (R.M.S., A.M.L., R.J.K.), and the Division of Neonatology, Columbia Hospital for Women, Washington, D.C. (J.W.S.).

Address reprint requests to Ms. Schwartz at the National Perinatal Information Center, One State St., Suite 102, Providence, RI 02908.

Full Text of this Article

This article has been cited by other articles:

• Darlow, B A, Gilbert, C, Quinn, G E, Azad, R, Ells, A L, Fielder, A, Zin, A (2009). Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity. Br J Ophthalmol 93: 986-986 [Full Text]  
• Delobel-Ayoub, M., Arnaud, C., White-Koning, M., Casper, C., Pierrat, V., Garel, M., Burguet, A., Roze, J.-C., Matis, J., Picaud, J.-C., Kaminski, M., Larroque, B., for the EPIPAGE Study Group, (2009). Behavioral Problems and Cognitive Performance at 5 Years of Age After Very Preterm Birth: The EPIPAGE Study. Pediatrics 123: 1485-1492 [Abstract] [Full Text]  
• Engle, W. A., and the Committee on Fetus and Newborn, (2008). Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate. Pediatrics 121: 419-432 [Abstract] [Full Text]  
• Telford, K, Waters, L, Vyas, H, Manktelow, B N, Draper, E S, Marlow, N (2007). Respiratory outcome in late childhood after neonatal continuous negative pressure ventilation. Arch. Dis. Child. Fetal Neonatal Ed. 92: F19-F24 [Abstract] [Full Text]  
• Ghodrat, M. (2006). Lung surfactants.. Am J Health Syst Pharm 63: 1504-1521 [Abstract] [Full Text]  
• Morales, L. S., Staiger, D., Horbar, J. D., Carpenter, J., Kenny, M., Geppert, J., Rogowski, J. (2005). Mortality Among Very Low-Birthweight Infants in Hospitals Serving Minority Populations. AJPH 95: 2206-2212 [Abstract] [Full Text]  
• Vohr, B. R., Wright, L. L., Poole, W. K., McDonald, S. A., for the NICHD Neonatal Research Network Follow-up, (2005). Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants <32 Weeks' Gestation Between 1993 and 1998. Pediatrics 116: 635-643 [Abstract] [Full Text]  
• Agrons, G. A., Courtney, S. E., Stocker, J. T., Markowitz, R. I. (2005). From the Archives of the AFIP: Lung Disease in Premature Neonates: Radiologic-Pathologic Correlation. RadioGraphics 25: 1047-1073 [Abstract] [Full Text]  
• Ho, S., Saigal, S. (2005). Current Survival and Early Outcomes of Infants of Borderline Viability. NeoReviews 6: e123-e132 [Full Text]  
• Laptook, A. R., O' Shea, T. M., Shankaran, S., Bhaskar, B., and the NICHD Neonatal Network, (2005). Adverse Neurodevelopmental Outcomes Among Extremely Low Birth Weight Infants With a Normal Head Ultrasound: Prevalence and Antecedents. Pediatrics 115: 673-680 [Abstract] [Full Text]  
• Lucey, J. F., Rowan, C. A., Shiono, P., Wilkinson, A. R., Kilpatrick, S., Payne, N. R., Horbar, J., Carpenter, J., Rogowski, J., Soll, R. F. (2004). Fetal Infants: The Fate of 4172 Infants With Birth Weights of 401 to 500 Grams--The Vermont Oxford Network Experience (1996-2000). Pediatrics 113: 1559-1566 [Abstract] [Full Text]  
• Cederqvist, K., Haglund, C., Heikkila, P., Sorsa, T., Tervahartiala, T., Stenman, U.-H., Andersson, S. (2003). Pulmonary Trypsin-2 in the Development of Bronchopulmonary Dysplasia in Preterm Infants. Pediatrics 112: 570-577 [Abstract] [Full Text]  
• Horbar, J. D., Badger, G. J., Carpenter, J. H., Fanaroff, A. A., Kilpatrick, S., LaCorte, M., Phibbs, R., Soll, R. F. (2002). Trends in Mortality and Morbidity for Very Low Birth Weight Infants, 1991-1999. Pediatrics 110: 143-151 [Abstract] [Full Text]  
• Richardson, D. K. (2001). A Woman With an Extremely Premature Newborn. JAMA 286: 1498-1505 [Full Text]  
• Hacking, D, Watkins, A, Fraser, S, Wolfe, R, Nolan, T (2001). Respiratory distress syndrome and birth order in premature twins. Arch. Dis. Child. Fetal Neonatal Ed. 84: 117F-121 [Abstract] [Full Text]  
• Stevenson, D K, Verter, J, Fanaroff, A A, Oh, W, Ehrenkranz, R A, Shankaran, S, Donovan, E F, Wright, L L, Lemons, J A, Tyson, J E, Korones, S B, Bauer, C R, Stoll, B J, Papile, L-A (2000). Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch. Dis. Child. Fetal Neonatal Ed. 83: 182F-185 [Abstract] [Full Text]  
• Fitzgerald, D. A., Mesiano, G., Brosseau, L., Davis, G. M. (2000). Pulmonary Outcome in Extremely Low Birth Weight Infants. Pediatrics 105: 1209-1215 [Abstract] [Full Text]  
• Vohr, B. R., Wright, L. L., Dusick, A. M., Mele, L., Verter, J., Steichen, J. J., Simon, N. P., Wilson, D. C., Broyles, S., Bauer, C. R., Delaney-Black, V., Yolton, K. A., Fleisher, B. E., Papile, L.-A., Kaplan, M. D. (2000). Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 105: 1216-1226 [Abstract] [Full Text]  
• Gould, J. B., Benitz, W. E., Liu, H. (2000). Mortality and Time to Death in Very Low Birth Weight Infants: California, 1987 and 1993. Pediatrics 105 : e37-e37 [Abstract] [Full Text]  
• Palta, M., Sadek-Badawi, M., Evans, M., Weinstein, M. R., McGuinness, G., for the Newborn Lung Project, (2000). Functional Assessment of a Multicenter Very Low-Birth-Weight Cohort at Age 5 Years. Arch Pediatr Adolesc Med 154: 23-30 [Abstract] [Full Text]  
• Guyer, B., Hoyert, D. L., Martin, J. A., Ventura, S. J., MacDorman, M. F., Strobino, D. M. (1999). Annual Summary of Vital Statistics---1998. Pediatrics 104: 1229-1246 [Abstract] [Full Text]  
• Lightwood, J. M., Phibbs, C. S., Glantz, S. A. (1999). Short-term Health and Economic Benefits of Smoking Cessation: Low Birth Weight. Pediatrics 104: 1312-1320 [Abstract] [Full Text]  
• Marshall, D. D., Kotelchuck, M., Young, T. E., Bose, C. L., Kruyer, L., O'Shea, T. M., the North Carolina Neonatologists Association, (1999). Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants. Pediatrics 104: 1345-1350 [Abstract] [Full Text]  
• Hills, B. A. (1999). An alternative view of the role(s) of surfactant and the alveolar model. J. Appl. Physiol. 87: 1567-1583 [Abstract] [Full Text]  
• Young, T. E., Kruyer, L. S., Marshall, D. D., Bose, C. L., the North Carolina Neonatologists Association, (1999). Population-based Study of Chronic Lung Disease in Very Low Birth Weight Infants in North Carolina in 1994 With Comparisons With 1984. Pediatrics 104: 17e-17 [Abstract] [Full Text]  
• Garland, J. S., Alex, C. P., Pauly, T. H., Whitehead, V. L., Brand, J., Winston, J. F., Samuels, D. P., McAuliffe, T. L. (1999). A Three-day Course of Dexamethasone Therapy to Prevent Chronic Lung Disease in Ventilated Neonates: A Randomized Trial. Pediatrics 104: 91-99 [Abstract] [Full Text]  
• Charafeddine, L., D'Angio, C. T., Phelps, D. L. (1999). Atypical Chronic Lung Disease Patterns in Neonates. Pediatrics 103: 759-765 [Abstract] [Full Text]  
• Committee on Fetus and Newborn, (1999). Surfactant Replacement Therapy for Respiratory Distress Syndrome. Pediatrics 103: 684-685 [Abstract] [Full Text]  
• Guyer, B., MacDorman, M. F., Martin, J. A., Peters, K. D., Strobino, D. M. (1998). Annual Summary of Vital Statistics---1997. Pediatrics 102: 1333-1349 [Abstract] [Full Text]  
• Richardson, D. K., Gray, J. E., Gortmaker, S. L., Goldmann, D. A., Pursley, D. M., McCormick, M. C. (1998). Declining Severity Adjusted Mortality: Evidence of Improving Neonatal Intensive Care. Pediatrics 102: 893-899 [Abstract] [Full Text]  
• Piecuch, R. E., Leonard, C. H., Cooper, B. A. (1998). Infants with Birth Weight 1,000-1,499 Grams Born in Three Time Periods: Has Outcome Changed Over Time?. CLIN PEDIATR 37: 537-545 [Abstract]  
• Rogowski, J. (1998). Cost-effectiveness of Care for Very Low Birth Weight Infants. Pediatrics 102: 35-43 [Abstract] [Full Text]  
• O'Shea, T. M., Preisser, J. S., Klinepeter, K. L., Dillard, R. G. (1998). Trends in Mortality and Cerebral Palsy in a Geographically Based Cohort of Very Low Birth Weight Neonates Born Between 1982 to 1994. Pediatrics 101: 642-647 [Abstract] [Full Text]  
• Racine, A. D., Joyce, T. J., Li, W., Chiasson, M. A. (1998). Recent Declines in New York City Infant Mortality Rates. Pediatrics 101: 682-688 [Abstract] [Full Text]  
• Guyer, B., Martin, J. A., MacDorman, M. F., Anderson, R. N., Strobino, D. M. (1997). Annual Summary of Vital Statistics---1996. Pediatrics 100: 905-918 [Abstract] [Full Text]  
• Schoendorf, K. C., Kiely, J. L. (1997). Birth Weight and Age-Specific Analysis of the 1990 US Infant Mortality Drop: Was It Surfactant?. Arch Pediatr Adolesc Med 151: 129-134 [Abstract]  
• Hamvas, A., Wise, P. H., Yang, R. K., Wampler, N. S., Noguchi, A., Maurer, M. M., Walentik, C. A., Schramm, W. F., Cole, F. S. (1996). The Influence of the Wider Use of Surfactant Therapy on Neonatal Mortality among Blacks and Whites. NEJM 334: 1635-1641 [Abstract] [Full Text]  
• Roth, J., Resnick, M. B., Ariet, M., Carter, R. L., Eitzman, D. V., Curran, J. S., Cupoli, J. M., Mahan, C. S., Bucciarelli, R. L. (1995). Changes in Survival Patterns of Very Low-Birth-Weight Infants From 1980 to 1993. Arch Pediatr Adolesc Med 149: 1311-1317 [Abstract]  
• (1994). SURFACTANT LOWERS MORTALITY AND COSTS IN NEWBORNS. JWatch General 1994: 4-4 [Full Text]